These results confirm the role of epigenetics in the obesity-related cardiovascular complications and firstly support the potential role of plasma miRNA-21 and IL-6 and NF-kB DNA methylation changes in nucleated blood cells as potential biomarkers for predicting cardiovascular risk in obesity. This evidence concerns the gene IL6 and obesity disorder.